FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012131086> ?p ?o ?g. }

• W2012131086 endingPage "939" @default.
• W2012131086 startingPage "929" @default.
• W2012131086 abstract "Multidrug resistance (MDR) is characterised by cross-resistance between unrelated anticancer drugs and is associated with the overexpression of a membrane bound high-molecular weight glycoprotein, named P-glycoprotein, which is able to actively expel the drugs out of the cells. In vitro, numerous compounds have demonstrated the ability to inhibit the transport activity of P-glycoprotein, resulting in enhanced intracellular drug accumulation and MDR reversal. Such compounds include drugs of current use in other therapeutic areas, such as verapamil, cyclosporin A, quinidine or tamoxifen. Clinical trials have been performed on these drugs with the aim of reversing drug-resistance, but their toxicity was often too high. Therefore pharmaceutical firms have preferred to evaluate either analogues of these drugs, or compounds specifically designed for resistance reversal. Drugs that have clearly shown a potential for sensitisation of resistant cancers with acceptable toxicity include dexverapamil one of the two enantiomers constituting verapamil, valspodar (PSC-833), an analogue of cyclosporine A, and original compounds, named VX-710 and GF-120918. Positive results have most often been obtained in haematological malignancies (myelomas, lymphomas and acute myeloblastic leukaemias), but sometimes also in solid tumours (breast and ovarian carcinomas). Randomised Phase III studies are ongoing for compounds showing a definite activity in Phase II studies, with the aim of analysing the benefits of the combination of an MDR reverter and conventional chemotherapy, in terms of patients’ survival. However, drug-resistance is a multifactorial phenomenon, with MDR constituting only part of it. In addition, a rigorous clinical evaluation of MDR will have to be performed, which has not always been the case in early trials." @default.
• W2012131086 created "2016-06-24" @default.
• W2012131086 creator A5023858440 @default.
• W2012131086 date "1998-06-01" @default.
• W2012131086 modified "2023-10-16" @default.
• W2012131086 title "Approaches to multidrug resistance reversal" @default.
• W2012131086 cites W1570070844 @default.
• W2012131086 cites W1754065147 @default.
• W2012131086 cites W1776168062 @default.
• W2012131086 cites W1885665794 @default.
• W2012131086 cites W1893346511 @default.
• W2012131086 cites W1925223276 @default.
• W2012131086 cites W1927327874 @default.
• W2012131086 cites W1933260678 @default.
• W2012131086 cites W1950536611 @default.
• W2012131086 cites W1964444964 @default.
• W2012131086 cites W1965785314 @default.
• W2012131086 cites W1971213222 @default.
• W2012131086 cites W1977660676 @default.
• W2012131086 cites W1981034185 @default.
• W2012131086 cites W1986025545 @default.
• W2012131086 cites W1998650250 @default.
• W2012131086 cites W2000375621 @default.
• W2012131086 cites W2003464317 @default.
• W2012131086 cites W2009396840 @default.
• W2012131086 cites W2012334764 @default.
• W2012131086 cites W2014593961 @default.
• W2012131086 cites W2016756053 @default.
• W2012131086 cites W2017239698 @default.
• W2012131086 cites W2017654394 @default.
• W2012131086 cites W2023520902 @default.
• W2012131086 cites W2023703396 @default.
• W2012131086 cites W2029185839 @default.
• W2012131086 cites W2033539216 @default.
• W2012131086 cites W2035142996 @default.
• W2012131086 cites W2040342801 @default.
• W2012131086 cites W2043143197 @default.
• W2012131086 cites W2044517385 @default.
• W2012131086 cites W2051002936 @default.
• W2012131086 cites W2051131881 @default.
• W2012131086 cites W2053969914 @default.
• W2012131086 cites W2064672868 @default.
• W2012131086 cites W2069491451 @default.
• W2012131086 cites W2069977591 @default.
• W2012131086 cites W2072834181 @default.
• W2012131086 cites W2076009547 @default.
• W2012131086 cites W2078822262 @default.
• W2012131086 cites W2079961141 @default.
• W2012131086 cites W2080328815 @default.
• W2012131086 cites W2083913321 @default.
• W2012131086 cites W2088419541 @default.
• W2012131086 cites W2094964562 @default.
• W2012131086 cites W2097878215 @default.
• W2012131086 cites W2099687525 @default.
• W2012131086 cites W2118234018 @default.
• W2012131086 cites W2119468178 @default.
• W2012131086 cites W2130613069 @default.
• W2012131086 cites W2153413276 @default.
• W2012131086 cites W2156213555 @default.
• W2012131086 cites W2198835790 @default.
• W2012131086 cites W2223026985 @default.
• W2012131086 cites W2253853328 @default.
• W2012131086 cites W2261384353 @default.
• W2012131086 cites W2290583892 @default.
• W2012131086 cites W2411255792 @default.
• W2012131086 cites W2416083307 @default.
• W2012131086 cites W2416522533 @default.
• W2012131086 cites W2465556950 @default.
• W2012131086 cites W2248114573 @default.
• W2012131086 doi "https://doi.org/10.1517/13543784.7.6.929" @default.
• W2012131086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15992007" @default.
• W2012131086 hasPublicationYear "1998" @default.
• W2012131086 type Work @default.
• W2012131086 sameAs 2012131086 @default.
• W2012131086 citedByCount "14" @default.
• W2012131086 countsByYear W20121310862014 @default.
• W2012131086 countsByYear W20121310862015 @default.
• W2012131086 countsByYear W20121310862019 @default.
• W2012131086 countsByYear W20121310862022 @default.
• W2012131086 crossrefType "journal-article" @default.
• W2012131086 hasAuthorship W2012131086A5023858440 @default.
• W2012131086 hasConcept C104317684 @default.
• W2012131086 hasConcept C114851261 @default.
• W2012131086 hasConcept C121608353 @default.
• W2012131086 hasConcept C126322002 @default.
• W2012131086 hasConcept C133936738 @default.
• W2012131086 hasConcept C149011108 @default.
• W2012131086 hasConcept C2776694085 @default.
• W2012131086 hasConcept C2777022698 @default.
• W2012131086 hasConcept C2777176818 @default.
• W2012131086 hasConcept C2778707650 @default.
• W2012131086 hasConcept C2780035454 @default.
• W2012131086 hasConcept C2780339425 @default.
• W2012131086 hasConcept C29730261 @default.
• W2012131086 hasConcept C44312359 @default.
• W2012131086 hasConcept C519063684 @default.
• W2012131086 hasConcept C530470458 @default.
• W2012131086 hasConcept C55493867 @default.

• next